Related Experiment Video
Updated: Aug 5, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Encoding Discordance in the Alzheimer's Disease A/T/N Framework
A new hybrid method accurately predicts Alzheimer's disease (AD) up to four years in advance using the amyloid/tau/neurodegeneration (A/T/N) framework. This approach enhances early AD screening by offering interpretable predictions.
Area of Science:
- Neuroscience
- Biomarker Research
- Artificial Intelligence in Medicine
Background:
- The amyloid/tau/neurodegeneration (A/T/N) framework is widely used in Alzheimer's disease (AD) research for staging.
- Existing methods using the A/T/N framework often compromise between adaptivity and interpretability.
- There is a need for advanced methods to improve early AD detection and prediction.
Purpose of the Study:
- To develop an interpretable, hybrid method for predicting incident Alzheimer's disease (AD).
- To leverage the A/T/N framework in a novel, data-driven yet interpretable manner.
- To enhance the accuracy and early detection capabilities for AD.
Main Methods:
- Introduced Neurosymodal Data Fusion, an interpretable, hybrid approach.
- Encoded the A/T/N framework as a logic program.
- Utilized neural networks to extract input biomarker features for AD prediction.
Main Results:
- Achieved up to 0.84 sensitivity in predicting four-year incident AD.
- Generated scores for A/T/N profiles, indicating relative importance for predictions.
- Identified potential limitations of current empirical cut-off values for A and T biomarkers in the ADNI dataset.
Conclusions:
- The developed pipeline offers a novel application of the A/T/N framework.
- This method has the potential to significantly improve early AD screening.
- The approach could enable earlier identification of AD years before clinical symptoms manifest.
More Related Videos
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction
Alzheimer's Disease: Treatment
Alzheimer Disease ll: Pathophysiology
Dementia
The progression of dementia is generally gradual.